Melatonin-Sprayed fruits: a new superfood?
NCT ID NCT07192835
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether treating fruits like lemons, blood oranges, and cherries with melatonin before harvest helps the body absorb more healthy plant compounds. Twenty-two healthy adults drank juice from treated or untreated fruits and provided urine samples to measure absorption. The goal is to see if this simple farming step could make fruits even healthier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Melatonin-treated fruit juice (lemon, blood orange, or sweet cherry)
- What this could lead to
- If successful, this could show that preharvest melatonin treatment of fruits enhances the body's uptake of beneficial plant compounds, potentially improving dietary strategies for health.
- What could go wrong
- This is a small, early-stage study with only 22 healthy participants, so results may not apply to the general population. The focus is on absorption, not on treating any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIETARY BIOAVAILABILITY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Miguel Hernandez
Orihuela, Alicante/Alacant, 03312, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test